These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pituitary-thyroid interaction: effects of thyroid hormone, non thyroidal illness and various agents on TSH secretion. Vagenakis AG Acta Med Austriaca; 1988; 15 Suppl 1():52-6. PubMed ID: 3140559 [TBL] [Abstract][Full Text] [Related]
23. Pituitary resistance to thyroid hormone action with preserved circadian rhythm of thyrotropin in a postmenopausal woman. Custro N; Scafidi V; Notarbartolo A J Endocrinol Invest; 1992 Feb; 15(2):121-6. PubMed ID: 1569287 [TBL] [Abstract][Full Text] [Related]
24. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. Bayer MF; Kriss JP; McDougall IR J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528 [TBL] [Abstract][Full Text] [Related]
25. Amniotic fluid concentrations of iodothyronines and thyrotropin do not reliably predict fetal thyroid status in pregnancies complicated by maternal thyroid disorders or anencephaly. Hollingsworth DR; Alexander NM J Clin Endocrinol Metab; 1983 Aug; 57(2):349-55. PubMed ID: 6863480 [TBL] [Abstract][Full Text] [Related]
26. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575 [TBL] [Abstract][Full Text] [Related]
27. [Inappropriate thyrotropin secretion. Part 2: non tumoral (author's transl)]. Hamon P; Baulieu JL; Doumith R; Jambart S; Turpin G Nouv Presse Med; 1981 Jun; 10(28):2361-4. PubMed ID: 6791128 [TBL] [Abstract][Full Text] [Related]
28. Thyroid hormone in hypopituitarism, Graves' disease, congenital hypothyroidism, and maternal thyroid disease during pregnancy. LaFranchi S Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S20-4. PubMed ID: 16707271 [TBL] [Abstract][Full Text] [Related]
29. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy. Hamon P; Bovier-Lapierre M; Robert M; Peynaud D; Pugeat M; Orgiazzi J J Clin Endocrinol Metab; 1988 Nov; 67(5):1089-93. PubMed ID: 3182960 [TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma. Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133 [TBL] [Abstract][Full Text] [Related]
31. A patient with thyrotropinoma cosecreting growth hormone and follicle-stimulating hormone with low alpha-glycoprotein: a new subentity? Elhadd TA; Ghosh S; Teoh WL; Trevethick KA; Hanzely Z; Dunn LT; Malik IA; Collier A Thyroid; 2009 Aug; 19(8):899-903. PubMed ID: 19534624 [TBL] [Abstract][Full Text] [Related]
33. Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. Gurnell M; Rajanayagam O; Barbar I; Jones MK; Chatterjee VK Thyroid; 1998 Aug; 8(8):679-82. PubMed ID: 9737363 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease. Wan Nazaimoon WM; Khalid BA Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636 [TBL] [Abstract][Full Text] [Related]
35. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients. Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435 [TBL] [Abstract][Full Text] [Related]
36. Hyperthyroidism due to thyrotropin-secreting pituitary tumors. Diagnostic and therapeutic considerations. Smallridge RC; Smith CE Arch Intern Med; 1983 Mar; 143(3):503-7. PubMed ID: 6338852 [TBL] [Abstract][Full Text] [Related]
37. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients. Brokken LJ; Wiersinga WM; Prummel MF J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276 [TBL] [Abstract][Full Text] [Related]
38. [Principles of thyroid hormone treatment (author's transl)]. Pfannenstiel P MMW Munch Med Wochenschr; 1980 Jun; 122(26):961-6. PubMed ID: 6775193 [TBL] [Abstract][Full Text] [Related]
39. A thyrotropin-secreting macroadenoma with positive growth hormone and prolactin immunostaining: A case report and literature review. Kuzu F; Bayraktaroğlu T; Zor F; G N BD; Salihoğlu YS; Kalaycı M Niger J Clin Pract; 2015; 18(5):693-7. PubMed ID: 26096253 [TBL] [Abstract][Full Text] [Related]
40. Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment. Özerdem A; Tunca Z; Çımrın D; Hıdıroğlu C; Ergör G Bipolar Disord; 2014 Feb; 16(1):72-82. PubMed ID: 24330379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]